Professional
Added to YB: 2023-02-24
Pitch date: 2023-02-24
MTCR [bullish]
Metacrine, Inc.
+3.86%
current return
Author Info
Special Situation Investments focuses on event-driven trades and low risk arbitrage opportunities with short term catalysts. Sign up for the newsletter.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases.
Market Cap
$25.5M
Pitch Price
$0.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.38
P/E
-0.60
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
Metacrine (MTCR) - Liquidation - 20% Upside
A summary for this pitch has not been created yet.
Read full article (1 min)